Showing 7,321 - 7,340 results of 7,592 for search 'common (programme OR programs)', query time: 0.19s Refine Results
  1. 7321
  2. 7322
  3. 7323
  4. 7324

    Optimization of Heat Transfer Area and Steam Requirement in Multiple Effects Evaporator for Concentration of Juice in Sugar Factory by Suratno Lourentius, Aning Ayucitra

    Published 2023-08-01
    “…A quadruple effect evaporator is commonly utilized in sugar factories in Indonesia. …”
    Get full text
    Article
  5. 7325

    A Cross-Sectional Study on Side Effects of “Corbevax” Covid-19 Vaccine among 12- to 14-Year Age Group in a Tertiary Care Hospital in Meerut, Uttar Pradesh by Chhaya Mittal, Harimu Bargayary, Mohit Saini

    Published 2025-01-01
    “…Background: The first mass vaccination program for COVID-19 in India started on January 16, 2021. …”
    Get full text
    Article
  6. 7326

    A mixed-method study to improve outcome of mass drug administration in two TAS failed districts of Uttar Pradesh, India. by Achintya Srivatsa, Padmalochan Biswal, Satyabrata Routray, Shweta Prasad, Kevin Bardosh, Paresh Kumar, Amresh Kumar, Aurpit Patnaik, Shoaib Anwar, Vindu Prakash Singh

    Published 2025-07-01
    “…Lymphatic filariasis (LF), commonly called "elephantiasis," is one of the leading causes of disability around the world, with approximately 863 million people across 47 countries still living under threat of LF infection. …”
    Get full text
    Article
  7. 7327
  8. 7328
  9. 7329

    Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy by Santosh Kesari, Jose Carrillo, Alexandra Drakaki, Joanne Weidhaas, Mark Scholz, Nicholas Marco, Aaron W Scheffler, Anusha Kalbasi, Kirk Wilenius, Emily Rietdorf, Jaya Gill, Mara Heilig, Caroline Desler, Robert K Chin, Tania Kaprealian, Susan McCloskey, Ann Raldow, Naga P Raja, Donatello Telesca

    Published 2022-02-01
    “…Treatment with the first drugs in this class, anti-programmed death 1 (anti-PD1)/programmed death-ligand 1 (PDL1) checkpoint therapies, results in grade 2 or higher irAEs in up to 25%–30% of patients, which occur most commonly within the first 6 months of treatment and can include arthralgias, rash, pruritus, pneumonitis, diarrhea and/or colitis, hepatitis, and endocrinopathies. …”
    Get full text
    Article
  10. 7330
  11. 7331
  12. 7332

    ATYPICAL HEMOLYTIC UREMIC SYNDROME DIAGNOSIS AND TREATMENT by Atakan Turgutkaya

    Published 2024-12-01
    “…Atypical hemolytic uremic syndrome (aHUS), more commonly known as complement-related HUS is a kind of thrombotic microangiopathy (TMA) characterized by inherited pathogenic variants in complement genes or acquired autoantibodies against complement factors, predominantly involving kidney [1]. …”
    Get full text
    Article
  13. 7333

    Impact of Wall Paint Solar Absorptance on CO<sub>2</sub> Emissions in Residential Buildings: A Case Study from Bangkok by Rungroj Wongmahasiri, Tarid Wongvorachan, Chaniporn Thampanichwat, Suphat Bunyarittikit

    Published 2024-12-01
    “…The aim of this study was to assess the potential reduction in greenhouse gas emissions through the use of appropriate solar absorptance in wall paint, conducted via an energy simulation using a representative residential building model from Bangkok. The DOE2.1E program was employed to simulate a standard two-story house commonly found in Thailand, with an approximate floor area of 120 square meters. …”
    Get full text
    Article
  14. 7334

    Development and Validation of Rapid Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification for Detection of Rift Valley Fever Virus by Francis Wekesa, Mark Wamalwa, Richard Oduor, Yatinder Binepal, Leonard Ateya, Noah Okumu, Angela M’kwenda, Christopher Masaba, Eugine Mukhaye

    Published 2023-01-01
    “…The developed RT-LAMP was found to be tenfold more sensitive compared to the RVFV qRT-PCR assay commonly used in the confirmatory diagnosis of RVFV.…”
    Get full text
    Article
  15. 7335

    Medical Rehabilitation Impact Towards Dynamic Balance in Lateral Ankle Sprain Patients by Moses Rizky Haryanto, Jonathan Salim, Nana Novia Jayadi, Mirna Phandu

    Published 2023-04-01
    “…Only the former participated in the three sessions of the rehabilitation program. The modified star excursion balance test was performed initially and three weeks later. …”
    Get full text
    Article
  16. 7336

    DRUG UTILIZATION REVIEW OF FLUOROQUINOLONES AMONG THE OUT-PATIENTS IN A PUBLIC SECTOR HOSPITAL, PAKISTAN by Awais Arshaad, Shahzaib Sharafat, Ayesha Mustafa, Hamza Mahmood, Fatima Mustafa, Sonia Tariq, Ammara Asif

    Published 2023-03-01
    “…Encounter with antibiotic and injection prescribed were 79.3% and 5.3%, respectively. The most commonly prescribed anti-biotic was ciprofloxacin followed by levofloxacin (maximum defined daily dose). …”
    Get full text
    Article
  17. 7337

    The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses by Claudio Scuoppo, Rick Ramirez, Siok F. Leong, Mark Koester, Zachary F. Mattes, Karen Mendelson, Julia Diehl, Franco Abbate, Erin Gallagher, Lila Ghamsari, Abi Vainstein-Haras, Gene Merutka, Barry J. Kappel, Jim A. Rotolo

    Published 2025-03-01
    “…Immune-checkpoint inhibitors (ICIs) have shown unprecedented success in a subset of immunogenic tumors, however a host of patients with advanced solid tumors fail to respond well or at all to immunotherapy. Refractory tumors commonly display a tumor microenvironment (TME) rich in immunosuppressive macrophages (M2-like) that suppress adaptive immunity and promote tumor progression. …”
    Get full text
    Article
  18. 7338

    Plasma levels of soluble PD-1, TIM-3, LAG-3 and galectin-3 and the degree of liver fibrosis in CHC and the impact of successful antiviral treatment on their levels by Sylwia Osuch, Aleksandra Kumorek, Paweł Kozłowski, Hanna Berak, Anna Maria Kochanowicz, Kamila Cortés-Fendorf

    Published 2025-05-01
    “…Abstract Chronic hepatitis C (CHC), caused by the hepatitis C virus, commonly leads to liver fibrosis. CHC is also related to T-cell exhaustion, phenotypically manifesting as overexpression of inhibitory receptors (iRs), e.g., programmed death receptor-1 (PD-1), T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) and lymphocyte activation gene 3 (LAG-3), which have corresponding plasma-soluble analogs. …”
    Get full text
    Article
  19. 7339
  20. 7340